Business Wire03.10.17
joimax is further ensuring its market access in Asia.
The German developer of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence, and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax products. Thus, joimax is well-prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest-growing region of the world,” said Wolfgang Ries, founder and CEO of joimax.
For years, joimax has been working with the Korean Wooridul group, the world’s largest specialized spine hospital network. Starting this year, joimax is joining together with the Wooridul Hospital in Seoul, South Korea, to offer international courses for minimally invasive spinal surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.
Founded in Karlsruhe, Germany, in 2001, joimax develops and markets complete systems for endoscopic minimally invasive spinal surgery. With TESSYS (transforaminal), iLESSYS (interlaminar) and CESSYS (cervical) for decompression procedures, MultiZYTE RT (e.g. for rhizotomy) and with MultiZYTE SI for SI-Joint therapy or with EndoLIF and Percusys for endoscopic minimally-invasive assisted stabilizations, proven endoscopic systems are provided that, together, cover a whole variety of indications.
In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax technologies to operate through small incisions through tissue- and muscle-sparing corridors through natural openings into the spinal canal (e.g. intervertebral foramen, the “Kambin triangle”).
The German developer of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence, and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax products. Thus, joimax is well-prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest-growing region of the world,” said Wolfgang Ries, founder and CEO of joimax.
For years, joimax has been working with the Korean Wooridul group, the world’s largest specialized spine hospital network. Starting this year, joimax is joining together with the Wooridul Hospital in Seoul, South Korea, to offer international courses for minimally invasive spinal surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.
Founded in Karlsruhe, Germany, in 2001, joimax develops and markets complete systems for endoscopic minimally invasive spinal surgery. With TESSYS (transforaminal), iLESSYS (interlaminar) and CESSYS (cervical) for decompression procedures, MultiZYTE RT (e.g. for rhizotomy) and with MultiZYTE SI for SI-Joint therapy or with EndoLIF and Percusys for endoscopic minimally-invasive assisted stabilizations, proven endoscopic systems are provided that, together, cover a whole variety of indications.
In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax technologies to operate through small incisions through tissue- and muscle-sparing corridors through natural openings into the spinal canal (e.g. intervertebral foramen, the “Kambin triangle”).